Huperzia Serrate Extract CAS 102518-79-6 Huperzine a 1% Huperzine Powder

• Customization: Available
• Product Name: Huperzine a
• Other Name: Huperzia Serrate Extract
• Model NO.: TGY2022050508
• CAS No.: 102518-79-6
• Einecs: 600-320-6
• Mf: C15h18n2o
• Molecular Weight: 242.32
• Content: 1%
• Grade: Daily Chemical/ Food
• Brand: Tgy
• Hazardous Chemicals: No
• Package: 100g, 1kg, 25kg
• Storage: Cool Dry Place
• Shelf Life: 2 Years
• Transport Package: Plastic Bag/ Bottle
• Specification: powder
• Trademark: TGYBIO
• Origin: China Mainland
• HS Code: 2934991000
• Production Capacity: 400kg Per Month

Product Description

Product Name:(-)-Huperzine A

CAS No.:  102518-79-6

Molecular Formula: C15H18N2O

Molecular Weight: 242.32g/mol

Purity : 1% 5% 99% HPLC

Appearance:  Brown Powder

Solubility :Soluble in methaol slightly soluble in water Fat soluble

Typical use:Treatment Alzheimer's disease,Novel
 Antidepressants,Weight Loss 

Standard Packing : 100gram,1kg

Shelf Life :2 years
Storage:Room temperature away from light

Huperzia serrata (TCM = Qian Ceng Ta) is a plant known as a firmoss which contains the acetylcholinesterase inhibitor huperzine A.It is widely distributed over-the-counter as a nootropic anddietary supplement. Extact from the plants huperzia serrata is the treatment of senile dementia specitic drug that can improve people's memory.

Huperzia serrata is luxuriant plants, it has the total of eight varieties of medicinal plants in China.This species is native to India and southeast Asia.Huperzine A is a naturally occurring sesquiterpene alkaloid compound found in the firmoss Huperzia serrata.Huperzine A has been found, through multiple studies, to be effective as a medicine for helping people with neurological conditions such as Alzheimer's disease.Huperzine A is also marketed as a dietary supplement with claims made for its ability to improve memory and mental function.

Huperzine A may also have a possible role in the treatment of myasthenia gravis.

Clinical trials show that this product is suitable for benign memory disorders. It can improve patients' abilities
of pointing memory, associative learning, image recall, meaningless graphic recognition and portrait recall,
and also enhance the learning and memory of normal people; This product can also improve the memory
impairment caused by dementia patients and brain organic diseases.

Huperzine A is clinically applicable to the treatment of the following symptoms:
1. It is used to treat and improve the memory impairment of middle-aged and elderly people and improve the
associative memory function; It is used to reduce memory caused by excessive use of brain and improve
learning and work efficiency;
2. It is used for memory impairment associated with neurasthenia;
3. Huperzine A is used for memory loss caused by cerebrovascular disorders;
4. It is used to improve the memory of Alzheimer's disease, which has obvious curative effect on improving
and restoring the cognitive and memory function of patients and improving the abnormal emotional behavior;
5. For the treatment of myasthenia gravis;
6. Huperzine A can improve the association disorder, cognitive impairment and memory loss associated
with schizophrenia;
7. It can improve the memory impairment associated with a variety of brain diseases and somatic diseases.
1. As pharmaceutical raw materials for memory impaired cognitive function and emotional behavior;
2. As the raw material of product for Improving memory, thinking;
3. Can be used in the treatment of myasthenia gravis;